AskTheDate.com
Back to calendar

Crescent Biopharma, Inc. (CBIO) Earnings

CBIO reports earnings on Thursday, July 30, 2026

earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.78
Actual EPS: $-0.70
EPS surprise: 20.33%
Company overview
Market Cap$422.0M
PriceUSD 15.30
EPS (TTM)-12.48
52-week high27.41
52-week low8.72
SectorHealth Technology
IndustryBiotechnology
Employees44